Compounds > trimethoprim--sulfamethoxazole-drug-combination

trimethoprim--sulfamethoxazole-drug-combination and amifloxacin

trimethoprim--sulfamethoxazole-drug-combination has been researched along with amifloxacin* in 1 studies

Trials

1 trial(s) available for trimethoprim--sulfamethoxazole-drug-combination and amifloxacin

ArticleYear
Randomized, controlled trial of a 10-day course of amifloxacin versus trimethoprim-sulfamethoxazole in the treatment of acute, uncomplicated urinary tract infection. Amifloxacin Multi-Center Trial Group.
    Antimicrobial agents and chemotherapy, 1990, Volume: 34, Issue:4

    We conducted a randomized controlled trial of orally administered amifloxacin versus trimethoprimsulfamethoxazole (TMP-SMX) as treatments of acute uncomplicated urinary tract infection in women. Amifloxacin at a dosage of 200 mg twice a day appeared as safe and effective as TMP-SMX, but amifloxacin at 400 mg twice a day tended to cause adverse events more frequently than did TMP-SMX.

    Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Randomized Controlled Trials as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

1990